Treatment of T-prolymphocytic leukemia with nonmyeloablative allogeneic stem cell transplantation

European Journal of Haematology

Volumn 66, Issue 2, 2001, Pages 137-139

  Garderet, L ^a,b   Bittencourt, H ^a   Kaliski, A ^a   Daniel, M T ^a   Ribaud, P ^a   Socie G ^a   Gluckman, E ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

Leukemic meningitis; Nonmyeloablative allogeneic transplantation; T prolymphocytic leukemia

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; FLUDARABINE; PREDNISONE; THYMOCYTE ANTIBODY; VINCRISTINE;

ADULT; ALLOTRANSPLANTATION; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEPATOSPLENOMEGALY; HUMAN; LEUKEMIC MENINGITIS; NEUTROPENIA; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; STEM CELL TRANSPLANTATION; T LYMPHOBLAST; TREATMENT OUTCOME;

FACIAL NERVE DISEASES; FATAL OUTCOME; FEMALE; GRAFT SURVIVAL; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, PROLYMPHOCYTIC; LEUKEMIA, T-CELL; MENINGITIS; MIDDLE AGED; NUCLEAR FAMILY; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035124595     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2001.00377.x     Document Type: Article

References (16)

1. Bone marrow transplantation for malignant disease
2. Engraftment of allogeneic hematopoietic progenitor cells with purine analog containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
3. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases
4. Prolymphocytic leukaemia of B and T cell type
5. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia
6. T-prolymphocytic leukemia
7. Cytogenetics studies on prolymphocytic leukemia. II - T cell prolymphocytic leukemia
8. Clinical and hematological response of chronic lymphocytic and prolymphocytic leukemia persisting after allogenic bone marrow transplantation with the onset of acute graft-versus-host disease: Possible role of graft-versus-leukemia
9. The role of pentostatine in the treatment of T-cell malignancies: Analysis of response rate in 145 patients according to disease subtype
10. Treatment of T-cell prolymphocytic leukemia with human C52 antibody
11. Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation
12. Leukemic meningitis in B-cell prolymphocytic leukemia. A clinical, pathologic, and ultrastuctural case study and a review of the literature
13. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia
14. Management of lymphoma recurrence after allogenic transplantation: The relevance of graft-versus-lymphoma effect
15. Transplant-lite: Induction of graft versus malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
16. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses